Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century

Figure 16 Difference in serotonin selective reuptake transporter immunoreactivity between a healthy subject and a patient with irritable bowel syndrome. A and B: Serotonin selective reuptake transporter immunoreactivity in the cytoplasm of the epithelial cells lining the rectal lumen (arrows) of a healthy subject (A) and of an irritable bowel syndrome patient (B).